Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 69 companies set new 52-week lows.
Codex DNA Q1 EPS $(0.45), Inline, Sales $5.60M Beat $3.90M Estimate
Codex DNA (NASDAQ:DNAY) reported quarterly losses of $(0.45) per share which met the analyst consensus estimate. This is a 68.53 percent increase over losses of $(1.43) per share from the same period last year. The
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Codex DNA Says Demonstrates Simple, Scalable, And Cell-Free Approach To Rapid MRNA Vaccine Design And Development At World Vaccine Congress Washington 2022
Codex DNA, Inc. (NASDAQ:DNAY), a pioneer in automated benchtop synthetic biology systems, today announced its speaker presentation for the World Vaccine Congress Washington 2022, which is being held in Washington, DC. on
Keybanc Maintains Overweight on Codex DNA, Lowers Price Target to $8
Keybanc analyst Paul Knight maintains Codex DNA (NASDAQ:DNAY) with a Overweight and lowers the price target from $30 to $8.